Discovery and Evaluation of TLR-Targeted Immune Agonists
Year: 2024
Type: article
Source: Journal of Medicinal Chemistry
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4402267477
